Astria Therapeutics
ATXS
ATXS
24 hedge funds and large institutions have $15.8M invested in Astria Therapeutics in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more ownership
Funds ownership: 0.55% → 0.55% (+0%)
Holders
24
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$512K | |
| 2 | +$281K | |
| 3 | +$218K | |
| 4 |
Renaissance Technologies
New York
|
+$129K |
| 5 |
OC
Oppenheimer & Co
New York
|
+$104K |
Top Sellers
| 1 | -$441K | |
| 2 | -$134K | |
| 3 | -$21K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$12.8K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7K |